News
Inizio launches strategic engagement offering to transform customer experiences
Inizio, a global commercialization partner dedicated to the health and life sciences industry, has announced the launch of a major new strategic combination at Inizio Engage. A purpose-built brand, set to change the way the industry interacts with its...
News
Phastar Statistics Manager Wins Prestigious DIA Award
Stephen Corson, Statistics Manager at specialist biometrics contract research organization (CRO) Phastar, has been chosen to receive the DIA 2023 Global Inspire Award for Community Engagement.
This prestigious award recognizes the outstanding contribution of DIA Community Chairs who consistently drive...
Clinical Trials
Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden
Mural Health, a clinical trials technology company that improves the patient and caregiver experience in clinical trials, has today announced a strategic partnership with ClinOne, the leading provider of adaptive clinical trial experience solutions. The move will integrate Mural...
News
Canton of Geneva supports Connect in Pharma 2023
The Canton of Geneva has announced its official support for Connect in Pharma 2023, a Geneva-based event bringing together European leaders in pharmaceuticals and healthcare to discuss the future of the global pharma and biopharma sector. Connect in Pharma’s...
News
Significance Of Mentorship for Healthcare Professionals
For years, the healthcare industry has been categorized as one of the world's most challenging, stressful, and yet somehow exciting industries. It also ranks high in knowledge, advancement, and having qualified personnel who know how to deal with complex...
Drug Research
Diosynvax Offers Lasting Defense Against COVID-19 Variants
Researchers have created a novel Covid-19 vaccine called DIOSynVax that can be administered using air-jet technology rather than a needle. This revolutionary vaccine aims to provide long-lasting protection against not only SARS-CoV-2 but also other related diseases.
Traditionally, the body's...
Drug Research
Overactive Protein Responsible For Severe Skin Disorder
A significant breakthrough has been made by researchers from the National Institutes of Health (NIH) in collaboration with scientists from the University of California San Diego (UCSD) and the University of Pittsburgh in understanding and potentially treating a rare...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















